Celyad Oncology S.A.

CYAD · NASDAQ
Analyze with AI
$0.47−$0.07 (−12.96%)
At close:May 18, 2023, 8:00 PM UTC
P/E TTM-1.17
P/B TTM-2.44
P/S TTM43.92
Dividend Yield0%
EPS-$1.47
Beta1.693617
Valuation
PEG Ratio-0.07
FCF Yield-34.88%
EV / EBITDA-1.32
Quality
ROIC-320.35%
Gross Margin-134.41%
Cash Conv. Ratio1.25
Growth
Revenue 3Y CAGR
FCF Growth0.00%
Safety
Net Debt / EBITDA-0.01
Interest Coverage-66.90
Efficiency
Inventory Turnover1.71
Cash Conv. Cycle933.85

Celyad Oncology S.A. (CYAD) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Celyad Oncology S.A. (CYAD) stock price today?

As of May 18, 2023, 8:00 PM UTC, Celyad Oncology S.A. (CYAD) stock is trading at $0.47. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CYAD stock quotes for informed trading decisions.

What is Celyad Oncology S.A.'s market capitalization?

Celyad Oncology S.A. (CYAD) has a market capitalization of approximately $14.2M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Celyad Oncology S.A.'s size relative to other companies in the USD market. The market cap figure updates automatically as the CYAD stock price changes.

What is the 52-week range for Celyad Oncology S.A. stock?

Celyad Oncology S.A. (CYAD) stock has traded in a 52-week range of $0.15 — $3.07. The 52-week range shows the highest and lowest prices at which CYAD traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Celyad Oncology S.A. stock price to this range provides context for recent price action.

How much trading volume does Celyad Oncology S.A. stock have?

Celyad Oncology S.A. (CYAD) stock recently traded approximately 49K shares. Trading volume indicates market liquidity and investor interest in CYAD. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Celyad Oncology S.A. stock.

Does Celyad Oncology S.A. pay dividends to shareholders?

Yes, Celyad Oncology S.A. (CYAD) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Celyad Oncology S.A. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Celyad Oncology S.A.'s intraday price range?

Today, Celyad Oncology S.A. (CYAD) stock has traded in a range of $0.47 — $0.528. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CYAD's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Celyad Oncology S.A. stock data?

AlphaPilot sources real-time CYAD stock quotes, fundamental financial data, and historical price charts for Celyad Oncology S.A. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Celyad Oncology S.A. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CYAD stock performance.